RBI Surprises with 25 bps Rate Cut to 625 Nomura Warns Policy Framework Diluted
Bank Nifty Underperforms Nifty 50 as Analysts Eye Selective PSU Bank Opportunities Amid Margin Pressures
Windex Misuse Could Lead to Costly Damages What Consumers Should Avoid
Truist Raises Flywire Price Target After Strong Q1 Revenue Beat and Guidance Boost
Reliance Industries Sets AGM for June 19 Market Eyes Jio IPO Clarity
First Trust ETFs Attract 406 Million in Inflows ETF League Tables Show
DMLP Q4 2024 Earnings EPS of 024 Reported Amid Stock Decline
FMAO Q1 2026 Earnings EPS Surpasses Estimates Amidst Challenging Interest Rate Environment
Mercury General MCY Q1 2026 Earnings Massive EPS Surprise on Strong Underwriting Yet Shares Edge Lower
Loews Corporation Q1 2026 Earnings EPS of 163 Driven by Diversified Portfolio
Sonoma Pharmaceuticals Inc SNOA Q1 2026 Earnings EPS Slightly Misses Estimates Amid Thin Revenue Disclosures
Archer Aviation ACHR Q1 2026 Earnings NarrowerthanExpected Loss Amid PreRevenue Progress
Gildan Activewear GIL Holds Steady Near 58 as Support and Resistance Levels Come into Focus
Indigo Acquisition Corp Unit INACU Holds Steady Near Trust Value Amid Limited Trading Activity
Omega Healthcare Investors Slides 106 as Support Levels Come into Focus
Kazia Therapeutics KZIA Faces Sharp Decline as Biotech Volatility Resurfaces
BGSF Inc BGSF Slides 323 as Selling Pressure Intensifies Below Resistance
Prediction Market Suggests SpaceX OpenAI and Anthropic Could Command FirstDay Valuations Above 14 Trillion
RYTHM Inc RYM Q3 2022 Earnings Deep EPS Miss Reflects Ongoing Operational Challenges
Blackrock MuniYield Quality Fund III MYI Gains 115 as Muni Bond Sentiment Improves
PD Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick
BANX Q4 2022 Earnings EPS Slightly Misses Estimates Amid Challenging Market Conditions
DLPN Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Edges Higher
Prudential Financial PRU Q1 2026 Earnings Solid EPS Beat Amid Mixed Market Signals
Cognition Therapeutics Inc CGTX Q1 2026 Earnings Narrower Loss on Lower Expenses No Revenue Reported
DAWN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Invests in Pipeline
ANGX Q1 2026 Earnings Earnings Beat Expectations Amid Revenue Uncertainty